FGFR3, fibroblast growth factor receptor 3, 2261

N. diseases: 654; N. variants: 55
Disease: Cognition Disorders ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0009241
Disease: Cognition Disorders
Cognition Disorders 		0.020 Biomarker group BEFREE Subtype-selective allosteric modulation of the M<sub>1</sub> muscarinic acetylcholine (ACh) receptor (M<sub>1</sub> mAChR) is an attractive approach for the treatment of numerous disorders, including cognitive deficits. 29777683 2018
CUI: C0009241
Disease: Cognition Disorders
Cognition Disorders 		0.020 Biomarker group BEFREE Positive allosteric modulators (PAMs) that target the M<sub>1</sub> muscarinic acetylcholine (ACh) receptor (M<sub>1</sub> mAChR) are potential treatments for cognitive deficits in conditions such as Alzheimer disease and schizophrenia. 29691279 2018